Kurs & Likviditet
Prenumeration
Kalender
2025-01-28 | Bokslutskommuniké 2024 |
2024-10-24 | Kvartalsrapport 2024-Q3 |
2024-07-12 | Kvartalsrapport 2024-Q2 |
2024-04-26 | Ordinarie utdelning XVIVO 0.00 SEK |
2024-04-25 | Årsstämma 2024 |
2024-04-24 | Kvartalsrapport 2024-Q1 |
2024-01-25 | Bokslutskommuniké 2023 |
2023-10-24 | Kvartalsrapport 2023-Q3 |
2023-07-13 | Kvartalsrapport 2023-Q2 |
2023-04-26 | Ordinarie utdelning XVIVO 0.00 SEK |
2023-04-25 | Årsstämma 2023 |
2023-04-24 | Kvartalsrapport 2023-Q1 |
2023-01-26 | Bokslutskommuniké 2022 |
2022-10-27 | Kvartalsrapport 2022-Q3 |
2022-07-13 | Kvartalsrapport 2022-Q2 |
2022-04-27 | Ordinarie utdelning XVIVO 0.00 SEK |
2022-04-26 | Årsstämma 2022 |
2022-04-25 | Kvartalsrapport 2022-Q1 |
2022-01-27 | Bokslutskommuniké 2021 |
2021-10-28 | Kvartalsrapport 2021-Q3 |
2021-07-13 | Kvartalsrapport 2021-Q2 |
2021-04-23 | Ordinarie utdelning XVIVO 0.00 SEK |
2021-04-22 | Årsstämma 2021 |
2021-04-21 | Kvartalsrapport 2021-Q1 |
2021-01-28 | Bokslutskommuniké 2020 |
2020-10-23 | Kvartalsrapport 2020-Q3 |
2020-10-14 | Extra Bolagsstämma 2020 |
2020-07-10 | Kvartalsrapport 2020-Q2 |
2020-04-09 | Kvartalsrapport 2020-Q1 |
2020-04-01 | Ordinarie utdelning XVIVO 0.00 SEK |
2020-03-31 | Årsstämma 2020 |
2020-01-30 | Bokslutskommuniké 2019 |
2019-10-24 | Kvartalsrapport 2019-Q3 |
2019-07-12 | Kvartalsrapport 2019-Q2 |
2019-04-26 | Ordinarie utdelning XVIVO 0.00 SEK |
2019-04-25 | Årsstämma 2019 |
2019-04-24 | Kvartalsrapport 2019-Q1 |
2019-02-08 | Bokslutskommuniké 2018 |
2018-10-26 | Kvartalsrapport 2018-Q3 |
2018-07-13 | Kvartalsrapport 2018-Q2 |
2018-04-30 | Ordinarie utdelning XVIVO 0.00 SEK |
2018-04-27 | Årsstämma 2018 |
2018-04-26 | Kvartalsrapport 2018-Q1 |
2018-02-09 | Bokslutskommuniké 2017 |
2017-10-27 | Kvartalsrapport 2017-Q3 |
2017-07-14 | Kvartalsrapport 2017-Q2 |
2017-04-27 | Ordinarie utdelning XVIVO 0.00 SEK |
2017-04-26 | Årsstämma 2017 |
2017-04-25 | Kvartalsrapport 2017-Q1 |
2017-04-10 | Extra Bolagsstämma 2017 |
2017-02-08 | Bokslutskommuniké 2016 |
2016-10-27 | Kvartalsrapport 2016-Q3 |
2016-07-15 | Kvartalsrapport 2016-Q2 |
2016-05-04 | Ordinarie utdelning XVIVO 0.00 SEK |
2016-05-03 | Årsstämma 2016 |
2016-04-26 | Kvartalsrapport 2016-Q1 |
2016-02-04 | Bokslutskommuniké 2015 |
2015-10-23 | Kvartalsrapport 2015-Q3 |
2015-08-13 | Kvartalsrapport 2015-Q2 |
2015-04-24 | Ordinarie utdelning XVIVO 0.00 SEK |
2015-04-23 | Årsstämma 2015 |
2015-04-22 | Kvartalsrapport 2015-Q1 |
2015-02-05 | Bokslutskommuniké 2014 |
2014-10-24 | Kvartalsrapport 2014-Q3 |
2014-10-24 | Analytiker möte 2014 |
2014-08-13 | Kvartalsrapport 2014-Q2 |
2014-04-30 | Ordinarie utdelning XVIVO 0.00 SEK |
2014-04-29 | Årsstämma 2014 |
2014-04-23 | Kvartalsrapport 2014-Q1 |
2014-02-07 | Bokslutskommuniké 2013 |
2013-11-07 | Analytiker möte 2013 |
2013-11-07 | Kvartalsrapport 2013-Q3 |
2013-07-11 | Kvartalsrapport 2013-Q2 |
2013-05-08 | Ordinarie utdelning XVIVO 0.00 SEK |
2013-05-07 | Årsstämma 2013 |
2013-04-19 | Kvartalsrapport 2013-Q1 |
2013-02-19 | Bokslutskommuniké 2012 |
2012-11-01 | Kvartalsrapport 2012-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
As of today, 30 September 2020, the total number of shares and votes in XVIVO Perfusion AB (publ) is 28,719,136. The number of shares and votes has changed as a result of the directed new issue of 2,118,640 shares that the company announced on 23 September 2020.
September 30, 2020
XVIVO Perfusion AB (publ)
For further information please contact:
Dag Andersson, CEO, +46 76 643 30 31, e-post: dag.andersson@xvivoperfusion.com
Christoffer Rosenblad, CFO, +46 73 519 21 59 e-post: christoffer.rosenblad@xvivoperfusion.com
About Us
XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation. The company is headquartered in Gothenburg, Sweden, and has one office in Lund, Sweden and one office in the USA. The XVIVO share is listed on Nasdaq Stockholm and has the ticker symbol XVIVO. More information can be found on the website www.xvivoperfusion.com.
This information is information that XVIVO Perfusion AB is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2020-09-30 08:30 CEST.